Assessment of the Correlation Between Renal Function Markers and Serum Ferritin Levels in Thalassemia Patients

被引:0
作者
Tammadondar, Mohammad [1 ]
Vatankhah, Ali [1 ]
Khatibzade-Nasari, Niloufar [2 ]
机构
[1] Hormozgan Univ Med Sci, Dept Internal Med, Bandar Abbas, Iran
[2] Islamic Azad Univ, Dept Med, Qeshm Branch, Qeshm, Iran
关键词
GLOMERULAR HYPERFILTRATION; IRON OVERLOAD; DYSFUNCTION; COMPLICATIONS; PREVALENCE; DIAGNOSIS;
D O I
10.1155/ijcp/6915906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: This study aimed to analyze renal function markers and correlate the results with serum ferritin levels in patients with thalassemia in Bandar Abbas, Iran, in 2020.Method: A cross-sectional study was conducted, and patients with a proven hemoglobinopathy diagnosis were included. Fasting blood was obtained to measure creatinine, sodium, potassium, calcium, phosphorus, magnesium, uric acid, and ferritin. In addition, a 24-h urine specimen was collected to determine the level of urine albumin, creatinine, sodium, potassium, calcium, phosphorus, magnesium, uric acid, and beta 2-microglobulin. Fractional excretion of sodium, potassium, calcium, phosphorus, magnesium, and uric acid was also calculated. Spearman's coefficient of correlation was used to determine the correlations between serum ferritin level and other variables.Results: Of the sixty-six patients studied, 3.0% had sickle cell thalassemia, 80.3% had major thalassemia, and 72.7% had intermediate thalassemia. In our study, serum ferritin, 24-h urine protein, and fractional excretion of sodium, calcium, and urine were higher than the normal range in thalassemia patients. There was a significant correlation between serum ferritin level and fractional excretion of magnesium, calcium, sodium, phosphorus, and uric acid with a negative correlation coefficient (p <= 0.05). We also found that the serum ferritin levels strongly correlated with microalbuminuria (p <= 0.05).
引用
收藏
页数:6
相关论文
共 26 条
[1]  
Adly A.A.M., 2014, EGYPTIAN J MED HUMAN, V15, P369, DOI [10.1016/j.ejmhg.2014.06.004, DOI 10.1016/J.EJMHG.2014.06.004]
[2]  
Ansari-Moghaddam A, 2018, EPIDEMIOL HEALTH, V40
[3]   Renal aspects of thalassaemia a changing paradigm [J].
Bhandari, Sunil ;
Galanello, Renzo .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (03) :187-197
[4]   Urinary Metabolic Profile of Patients with Transfusion-Dependent β-Thalassemia Major Undergoing Deferasirox Therapy [J].
Capolongo, Giovanna ;
Zacchia, Miriam ;
Beneduci, Amerigo ;
Costantini, Silvia ;
Cinque, Patrizia ;
Spasiano, Anna ;
De Luca, Giuseppina ;
Di Pietro, Maria Enrica ;
Ricchi, Paolo ;
Trepiccione, Francesco ;
Capasso, Giovambattista ;
Filosa, Aldo .
KIDNEY & BLOOD PRESSURE RESEARCH, 2020, 45 (03) :455-466
[5]   Beta-thalassemia: renal complications and mechanisms: a narrative review [J].
Demosthenous, Christos ;
Vlachaki, Efthymia ;
Apostolou, Chrysa ;
Eleftheriou, Perla ;
Kotsiafti, Aggeliki ;
Vetsiou, Evangelia ;
Mandala, Evdokia ;
Perifanis, Vassilios ;
Sarafidis, Pantelis .
HEMATOLOGY, 2019, 24 (01) :426-438
[6]   Documentation of renal glomerular and tubular impairment and glomerular hyperfiltration in multitransfused patients with beta thalassemia [J].
Deveci, Burak ;
Kurtoglu, Aysegul ;
Kurtoglu, Erdal ;
Salim, Ozan ;
Toptas, Tayfur .
ANNALS OF HEMATOLOGY, 2016, 95 (03) :375-381
[7]   Renal Dysfunction in Patients with Beta-Thalassemia Major Receiving Iron Chelation Therapy either with Deferoxamine and Deferiprone or with Deferasirox [J].
Economou, Marina ;
Printza, Nikoletta ;
Teli, Aikaterini ;
Tzimouli, Vassiliki ;
Tsatra, Ioanna ;
Papachristou, Fotis ;
Athanassiou-Metaxa, Miranda .
ACTA HAEMATOLOGICA, 2010, 123 (03) :148-152
[8]  
Executive Board, 2006, Thalassaemia and Other Haemoglobinopathies: Report by the Secretariat
[9]   Hemoglobinopathies Clinical Manifestations, Diagnosis, and Treatment [J].
Kohne, Elisabeth .
DEUTSCHES ARZTEBLATT INTERNATIONAL, 2011, 108 (31-32) :532-U21
[10]   Gene therapy and gene editing strategies for hemoglobinopathies [J].
Lidonnici, Maria Rosa ;
Ferrari, Giuliana .
BLOOD CELLS MOLECULES AND DISEASES, 2018, 70 :87-101